- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
45 Depression Trials near Orlando, FL
Power is an online platform that helps thousands of Depression patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerMM120 for Depression
Trial Details
Key Eligibility Criteria
140 Participants Needed
SEP-363856 for Major Depressive Disorder
Trial Details
Key Eligibility Criteria
900 Participants Needed
Psilocybin Analog for Depression
Trial Details
Key Eligibility Criteria
220 Participants Needed
Osavampator as an Adjunctive Treatment for Depression
Trial Details
Key Eligibility Criteria
200 Participants Needed
SP-624 for Depression
Trial Details
Key Eligibility Criteria
456 Participants Needed
Azetukalner for Depression
Trial Details
Key Eligibility Criteria
460 Participants Needed
Azetukalner for Depression
Trial Details
Key Eligibility Criteria
450 Participants Needed
Solriamfetol for Depression
Trial Details
Key Eligibility Criteria
300 Participants Needed
NMRA-335140 for Depression
Trial Details
Key Eligibility Criteria
332 Participants Needed
NMRA-335140 for Depression
Trial Details
Key Eligibility Criteria
650 Participants Needed
Cariprazine for Bipolar Disorder in Youth
Trial Details
Key Eligibility Criteria
380 Participants Needed
AXS-05 for Depression
Trial Details
Key Eligibility Criteria
350 Participants Needed
BI 1569912 for Depression
Trial Details
Key Eligibility Criteria
224 Participants Needed
Ropanicant for Depression
Trial Details
Key Eligibility Criteria
195 Participants Needed
Zelquistinel for Depression
Trial Details
Key Eligibility Criteria
164 Participants Needed
BHV-7000 for Depression
Trial Details
Key Eligibility Criteria
480 Participants Needed
ALTO-203 for Depression
Trial Details
Key Eligibility Criteria
60 Participants Needed
Centanafadine for Depression
Trial Details
Key Eligibility Criteria
336 Participants Needed
Fosigotifator for Depression
Trial Details
Key Eligibility Criteria
20 Participants Needed
ABX-002 for Depression
Trial Details
Key Eligibility Criteria
230 Participants Needed
Why Other Patients Applied
"Dealt with treatment-resistant depression for pretty much my entire life. I would be eternally grateful for something that actually worked for once. I'd just like to feel normal. "
"I have dealt with depression my entire adult life. I have been on multiple different meds, went through 10 weeks of TMS treatments (didn't work for me personally), done fairly extensive counseling. I’ve kind of lost hope that anything will ever help me to feel better. But I learned about new meds in clinical trials and I'm ready to try."
"I've experienced drug resistant MDD for 2 decades. I have had no success with CBT and medication, nor either alone. I had success once with TMS, about 5 sessions, in 2014. I have not had TMS since then."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"My long history of depression has been met with a long list of trial and error drugs. My current medication (generic Pristiq) has been prescribed for two decades (though I tried several other medications during my last serious episode several years ago. When the episode passed I returned to generic Pristiq. I am interested in a clinical trial because I wonder if I can do something different to more effectively avoid a serious depressive episode and lift the general malaise I often feel."
Lumateperone for Pediatric Bipolar Depression
Trial Details
Key Eligibility Criteria
384 Participants Needed
Psilocybin for Depression
Trial Details
Key Eligibility Criteria
240 Participants Needed
NORA520 for Postpartum Depression
Trial Details
Key Eligibility Criteria
90 Participants Needed
VNS for Bipolar Depression
Trial Details
Key Eligibility Criteria
6800 Participants Needed
Aticaprant + Antidepressant for Depression
Trial Details
Key Eligibility Criteria
660 Participants Needed
Digital Therapeutics for Depression
Trial Details
Key Eligibility Criteria
84 Participants Needed
Azetukalner for Bipolar Disorder
Trial Details
Key Eligibility Criteria
400 Participants Needed
Azetukalner for Bipolar Depression
Trial Details
Key Eligibility Criteria
400 Participants Needed
Single Session Intervention for Type 1 Diabetes
Trial Details
Key Eligibility Criteria
80 Participants Needed
Seltorexant for Depression
Trial Details
Key Eligibility Criteria
752 Participants Needed
Know someone looking for new options?
Spread the word
